Funding for this research was provided by:
National Institute of General Medical Sciences (U54GM088558, U54GM088558)
Article History
Received: 6 August 2018
Accepted: 19 February 2019
First Online: 5 March 2019
Ethics approval and consent to participate
: Not applicable
: Not applicable
: ML has received consulting income from Pfizer, Merck, Affinivax and Antigen Discovery, and research support through his institution from Pfizer and PATH.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.